These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

512 related items for PubMed ID: 24060642

  • 21. Template-based lymphadenectomy in urothelial carcinoma of the renal pelvis: a prospective study.
    Kondo T, Hara I, Takagi T, Kodama Y, Hashimoto Y, Kobayashi H, Iizuka J, Omae K, Yoshida K, Tanabe K.
    Int J Urol; 2014 May; 21(5):453-9. PubMed ID: 24754341
    [Abstract] [Full Text] [Related]

  • 22. IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder.
    Liang PI, Wang YH, Wu TF, Wu WR, Liao AC, Shen KH, Hsing CH, Shiue YL, Huang HY, Hsu HP, Chen LT, Lin CY, Tai C, Wu JY, Li CF.
    J Clin Pathol; 2013 Jul; 66(7):573-82. PubMed ID: 23539739
    [Abstract] [Full Text] [Related]

  • 23. Prospective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomy.
    Lotan Y, Bagrodia A, Passoni N, Rachakonda V, Kapur P, Arriaga Y, Bolenz C, Margulis V, Raj GV, Sagalowsky AI, Shariat SF.
    Eur Urol; 2013 Sep; 64(3):465-71. PubMed ID: 23571005
    [Abstract] [Full Text] [Related]

  • 24. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
    Sanderson KM, Cai J, Miranda G, Skinner DG, Stein JP.
    J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
    [Abstract] [Full Text] [Related]

  • 25. Characteristics of female non-muscle-invasive bladder cancer in Taiwan: association with upper tract urothelial carcinoma and end-stage renal disease.
    Chen CH, Shun CT, Huang KH, Huang CY, Yu HJ, Pu YS.
    Urology; 2008 Jun; 71(6):1155-60. PubMed ID: 18372011
    [Abstract] [Full Text] [Related]

  • 26. Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma.
    Soga N, Arima K, Sugimura Y.
    Int J Urol; 2008 Sep; 15(9):800-3. PubMed ID: 18651862
    [Abstract] [Full Text] [Related]

  • 27. Upper urinary tract recurrence after radical cystectomy for bladder cancer--who is at risk?
    Volkmer BG, Schnoeller T, Kuefer R, Gust K, Finter F, Hautmann RE.
    J Urol; 2009 Dec; 182(6):2632-7. PubMed ID: 19836794
    [Abstract] [Full Text] [Related]

  • 28. FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours.
    van Oers JM, Zwarthoff EC, Rehman I, Azzouzi AR, Cussenot O, Meuth M, Hamdy FC, Catto JW.
    Eur Urol; 2009 Mar; 55(3):650-7. PubMed ID: 18584939
    [Abstract] [Full Text] [Related]

  • 29. [European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. European Association of Urology Guideline Group for urothelial cell carcinoma of the upper urinary tract].
    Rouprêt M, Zigeuner R, Palou J, Boehle A, Kaasinen E, Sylvester R, Babjuk M, Oosterlinck W, European Association of Urology Guideline Group for urothelial cell carcinoma of the upper urinary tract.
    Actas Urol Esp; 2012 Jan; 36(1):2-14. PubMed ID: 22036956
    [Abstract] [Full Text] [Related]

  • 30. p53 mutations in multiple urothelial carcinomas: a molecular analysis of the development of multiple carcinomas.
    Goto K, Konomoto T, Hayashi K, Kinukawa N, Naito S, Kumazawa J, Tsuneyoshi M.
    Mod Pathol; 1997 May; 10(5):428-37. PubMed ID: 9160306
    [Abstract] [Full Text] [Related]

  • 31. Pattern of intravesical recurrence after surgical treatment for urothelial cancer of the upper urinary tract: a single institutional retrospective long-term follow-up study.
    Takaoka E, Hinotsu S, Joraku A, Oikawa T, Sekido N, Miyanaga N, Kawai K, Shimazui T, Akaza H.
    Int J Urol; 2010 Jul; 17(7):623-8. PubMed ID: 20412341
    [Abstract] [Full Text] [Related]

  • 32. Role of lymphadenectomy in the management of urothelial carcinoma of the bladder and the upper urinary tract.
    Kondo T, Tanabe K.
    Int J Urol; 2012 Aug; 19(8):710-21. PubMed ID: 22515472
    [Abstract] [Full Text] [Related]

  • 33. Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.
    Rink M, Robinson BD, Green DA, Cha EK, Hansen J, Comploj E, Margulis V, Raman JD, Ng CK, Remzi M, Bensalah K, Kabbani W, Haitel A, Rioux-Leclercq N, Guo CC, Chun FK, Kikuchi E, Kassouf W, Sircar K, Sun M, Sonpavde G, Lotan Y, Pycha A, Karakiewicz PI, Scherr DS, Shariat SF.
    J Urol; 2012 Aug; 188(2):398-404. PubMed ID: 22698626
    [Abstract] [Full Text] [Related]

  • 34. The outcome of patients on dialysis with upper urinary tract transitional cell carcinoma.
    Wu CF, Chang PL, Chen CS, Chuang CK, Weng HH, Pang ST.
    J Urol; 2006 Aug; 176(2):477-81. PubMed ID: 16813872
    [Abstract] [Full Text] [Related]

  • 35. [Urothelial carcinoma of the upper urinary tract. Survival and prognostic factors].
    Arrizabalaga Moreno M, Díez Rodríguez JM, García González JI, Esteban Arteaga R, Navarro Sebastián J, Castro Pita M, Mora Durban M, Paniagua Andrés P.
    Arch Esp Urol; 1998 Apr; 51(3):243-51. PubMed ID: 9622915
    [Abstract] [Full Text] [Related]

  • 36. Secondary bladder cancer after upper tract urothelial carcinoma in the US population.
    Kates M, Badalato GM, Gupta M, McKiernan JM.
    BJU Int; 2012 Nov; 110(9):1325-9. PubMed ID: 22564365
    [Abstract] [Full Text] [Related]

  • 37. Validation of the preoperative plasma fibrinogen level as a prognostic factor in a European cohort of patients with localized upper tract urothelial carcinoma.
    Pichler M, Dalpiaz O, Ehrlich GC, Stojakovic T, Martín Hernández JM, Mannweiler S, Pummer K, Zigeuner R, Hutterer GC.
    J Urol; 2014 Apr; 191(4):920-5. PubMed ID: 24513163
    [Abstract] [Full Text] [Related]

  • 38. Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration.
    Hellenthal NJ, Shariat SF, Margulis V, Karakiewicz PI, Roscigno M, Bolenz C, Remzi M, Weizer A, Zigeuner R, Bensalah K, Ng CK, Raman JD, Kikuchi E, Montorsi F, Oya M, Wood CG, Fernandez M, Evans CP, Koppie TM.
    J Urol; 2009 Sep; 182(3):900-6. PubMed ID: 19616245
    [Abstract] [Full Text] [Related]

  • 39. Microsatellite instability in multifocal urothelial carcinoma and effect on BAX and AXIN2.
    Walsh AM, Bailly GG, Bell DG, Norman RW, Gupta R, Zayed E, Nassar BA.
    Can J Urol; 2003 Oct; 10(5):2000-6. PubMed ID: 14633328
    [Abstract] [Full Text] [Related]

  • 40. Association of angiogenesis related markers with bladder cancer outcomes and other molecular markers.
    Shariat SF, Youssef RF, Gupta A, Chade DC, Karakiewicz PI, Isbarn H, Jeldres C, Sagalowsky AI, Ashfaq R, Lotan Y.
    J Urol; 2010 May; 183(5):1744-50. PubMed ID: 20299037
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.